Cetera Investment Advisers’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $53M | Buy |
107,789
+5,593
| +5% | +$3.04M | 0.06% | 354 |
|
|
2025
Q4 | $59.2M | Buy |
102,196
+5,693
| +6% | +$3.22M | 0.06% | 286 |
|
|
2025
Q3 | $46.8M | Buy |
96,503
+29,696
| +44% | +$13.8M | 0.05% | 343 |
|
|
2025
Q2 | $27.1M | Buy |
66,807
+989
| +2% | +$414K | 0.05% | 412 |
|
|
2025
Q1 | $32.8M | Buy |
65,818
+7,703
| +13% | +$4.17M | 0.06% | 314 |
|
|
2024
Q4 | $30.2M | Sell |
58,115
-2,078
| -3% | -$1.14M | 0.06% | 309 |
|
|
2024
Q3 | $37.2M | Buy |
60,193
+3,408
| +6% | +$2.02M | 0.08% | 244 |
|
|
2024
Q2 | $31.4M | Sell |
56,785
-129
| -0.2% | -$73.9K | 0.07% | 266 |
|
|
2024
Q1 | $33.1M | Buy |
56,914
+40,460
| +246% | +$22.7M | 0.08% | 258 |
|
|
2023
Q4 | $8.73M | Sell |
16,454
-945
| -5% | -$457K | 0.07% | 256 |
|
|
2023
Q3 | $8.81M | Sell |
17,399
-1,534
| -8% | -$817K | 0.08% | 255 |
|
|
2023
Q2 | $9.88M | Sell |
18,933
-766
| -4% | -$413K | 0.08% | 226 |
|
|
2023
Q1 | $11.4M | Sell |
19,699
-1,427
| -7% | -$804K | 0.1% | 193 |
|
|
2022
Q4 | $11.6M | Buy |
21,126
+8,937
| +73% | +$4.74M | 0.11% | 183 |
|
|
2022
Q3 | $6.18M | Sell |
12,189
-2,325
| -16% | -$1.3M | 0.12% | 174 |
|
|
2022
Q2 | $7.88M | Buy |
14,514
+578
| +4% | +$318K | 0.13% | 167 |
|
|
2022
Q1 | $8.23M | Buy |
13,936
+598
| +4% | +$344K | 0.12% | 182 |
|
|
2021
Q4 | $8.9M | Sell |
13,338
-1,051
| -7% | -$656K | 0.13% | 172 |
|
|
2021
Q3 | $8.22M | Buy |
14,389
+1,980
| +16% | +$1.09M | 0.13% | 172 |
|
|
2021
Q2 | $6.26M | Buy |
12,409
+2,059
| +20% | +$971K | 0.1% | 220 |
|
|
2021
Q1 | $4.72M | Sell |
10,350
-1,628
| -14% | -$777K | 0.09% | 236 |
|
|
2020
Q4 | $5.58M | Buy |
11,978
+8,588
| +253% | +$4.03M | 0.11% | 200 |
|
|
2020
Q3 | $1.5M | Sell |
3,390
-292
| -8% | -$121K | 0.12% | 194 |
|
|
2020
Q2 | $1.33M | Buy |
3,682
+96
| +3% | +$32.2K | 0.12% | 193 |
|
|
2020
Q1 | $1.02M | Buy |
3,586
+63
| +2% | +$19.9K | 0.12% | 191 |
|
|
2019
Q4 | $1.14M | Buy |
3,523
+187
| +6% | +$56.7K | 0.11% | 190 |
|
|
2019
Q3 | $972K | Buy |
3,336
+469
| +16% | +$134K | 0.12% | 192 |
|
|
2019
Q2 | $847K | Sell |
2,867
-31
| -1% | -$8.54K | 0.11% | 203 |
|
|
2019
Q1 | $793K | Buy |
2,898
+67
| +2% | +$16.7K | 0.11% | 199 |
|
|
2018
Q4 | $632K | Sell |
2,831
-438
| -13% | -$103K | 0.1% | 208 |
|
|
2018
Q3 | $794K | Buy |
3,269
+835
| +34% | +$192K | 0.11% | 193 |
|
|
2018
Q2 | $503K | Buy |
2,434
+357
| +17% | +$75.8K | 0.09% | 240 |
|
|
2018
Q1 | $429K | Buy |
+2,077
| New | +$436K | 0.08% | 248 |
|
Other funds holding TMO
VCM
Cetera Investment Advisers's TMO Position: Q1 2026 in Review
Cetera Investment Advisers increased its Thermo Fisher Scientific (TMO) stake by 5.5% in Q1 2026, buying an estimated $3.04M and bringing the position to 107,789 shares worth $53M. The position accounts for 0.06% of the portfolio, ranked #354.
Cetera Investment Advisers first reported a position in TMO in Q1 2018 and has held it in 33 quarters since. The position peaked at $59.2M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Cetera Investment Advisers held 107,789 shares of Thermo Fisher Scientific worth $53M as of Q1 2026.
- Cetera Investment Advisers bought 5,593 Thermo Fisher Scientific shares in Q1 2026, an estimated $3.04M.
- Thermo Fisher Scientific made up 0.06% of Cetera Investment Advisers's portfolio in Q1 2026, its #354 holding.
- Cetera Investment Advisers first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 33 quarters since.
- Cetera Investment Advisers's Thermo Fisher Scientific position peaked at $59.2M in Q4 2025.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.